Continuous Infusion Versus Bolus Dosing for Pain Control After Pediatric Cardiothoracic Surgery
Primary Purpose
Congenital Heart Disease
Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
continuous infusion
as needed dosing
Acetaminophen
ketorolac
Sponsored by
About this trial
This is an interventional treatment trial for Congenital Heart Disease focused on measuring congenital heart disease, pediatric cardiothoracic surgery
Eligibility Criteria
Inclusion Criteria:
- Age 3 months - 4 years (48 months)
- Anticipated cardiothoracic surgery with midline sternotomy incision
- Planned early extubation (e.g. within 3 hours post surgery)
Exclusion Criteria:
- Presence of renal insufficiency defined as a creatinine greater than 0.8mg/dL on the standard basic metabolic profile sent after surgery or history of chronic renal failure.
- Significant development delay that the bedside nurse or treating physician judges would make pain scoring difficult (Down syndrome is not excluded)
- History of bleeding disorder or gastrointestinal bleed within the past 2 months.
- Presence of chronic hepatic disease or elevation of AST or ALT greater than 250 U/L before or after surgery.
- More than 3 previous surgeries with a sternotomy incision (this may alter pain perception).
- Children on immunosuppressants
Sites / Locations
- Advocate Children's Hospital
Arms of the Study
Arm 1
Arm 2
Arm Type
Active Comparator
Active Comparator
Arm Label
Continuous infusion
As needed dosing
Arm Description
Patients in this group will received morphine/midazolam drips at 0.3 mg/kg/hour each. They will be given doses of morphine 0.05 mg/kg/dose every 2 hours as needed for pain score 4 or more. Midazolam will also be given as needed (0.05 mg/kg/dose every 1 hour)
Patients in this arm will be given doses of morphine 0.05 mg/kg/dose every 2 hours as needed for pain score 4 or more. Midazolam will also be given as needed (0.05 mg/kg/dose every 1 hour)
Outcomes
Primary Outcome Measures
Total Morphine Dosage
Total dose of morphine used will be recorded for each patient.
Secondary Outcome Measures
Length of Stay
Length of stay will be recorded for each subject.
Full Information
1. Study Identification
Unique Protocol Identification Number
NCT02112448
Brief Title
Continuous Infusion Versus Bolus Dosing for Pain Control After Pediatric Cardiothoracic Surgery
Official Title
Continuous Infusion Versus Bolus Dosing for Pain Control After Pediatric Cardiothoracic Surgery
Study Type
Interventional
2. Study Status
Record Verification Date
April 2017
Overall Recruitment Status
Completed
Study Start Date
June 2014 (undefined)
Primary Completion Date
May 2016 (Actual)
Study Completion Date
May 2016 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Advocate Health Care
4. Oversight
Data Monitoring Committee
Yes
5. Study Description
Brief Summary
The investigators hypothesize that intermittent bolus doses of morphine and midazolam can provide the same pain control after pediatric cardiothoracic surgery as bolus doses plus infusions while using smaller total doses of both medications.
The investigators will randomize patients to receive either morphine/midazolam as needed intermittently or morphine/midazolam drips plus intermittent doses to be received as needed. Pain scores will be recorded and total medications given will be recorded.
Detailed Description
Prior to surgery, eligible patients scheduled for surgery will be sent our standard surgery letter (Attachment A) along with our study informational sheet (Attachment B) describing our study. The study informational sheet will have a telephone number to call to set up a phone appointment to discuss the study with the PI should parents have questions not answered on the sheet. During the pre-operative visit, the study will again be discussed with the parents. Our nurse practitioners will be trained on this study and will obtain written consent at this time. If the parents would like to further discuss the study directly with the PI, this will be arranged prior to surgery.
The PI will be notified by the NPs of all parents who give permission for their child to participate in the study, and he will notify the on service medical team. On the day of surgery, a computerized order for the study will be entered to notify the pharmacy to randomize the subject to the control or treatment group. Randomization will be stratified based on whether the child has DS, as children with DS are known to have a heightened pain response and require large doses of medication to treat pain. Only the pharmacist will know the random assignment, health care providers and subjects/families will be blinded as to treatment arm.
Treatment Group:
Intravenous (IV) drip of 0.03 mg/kg/hour morphine and 0.03 mg/kg/hour midazolam
Control Group:
IV drip of normal saline (NS) at same volume as what the morphine/midazolam drip would be
Both Groups
Subjects in both the control and treatment group will receive the following post-operative pain control orders that are currently in use in the PSHU:
Morphine 0.05 mg/kg/dose IV q 2 hours prn pain score 4 or greater
Midazolam 0.05 mg/kg/dose IV q1 hours prn agitation
Additional prn doses of morphine and midazolam may be given as determined by the treating team (these doses will be recorded in the EMR)
Acetaminophen 30 mg/kg PR x 1 to be given on admission to PSHU post surgery
Acetaminophen 15 mg/kg PR q4 hours to be started 4 hours after first dose
Acetaminophen 15 mg/kg PO q4 hours to be started after subject starts drinking by mouth and PR doses stopped
Ketorolac 0.5 mg/kg/dose IV q 6 hours to start 6-12 hours after surgery when chest tube drainage criteria are met. Will start when chest tube drainage is no longer frankly bloody and if chest tube drainage is less than 3 cc/kg/hour for two hours in a row
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Congenital Heart Disease
Keywords
congenital heart disease, pediatric cardiothoracic surgery
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
ParticipantCare Provider
Allocation
Randomized
Enrollment
78 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Continuous infusion
Arm Type
Active Comparator
Arm Description
Patients in this group will received morphine/midazolam drips at 0.3 mg/kg/hour each. They will be given doses of morphine 0.05 mg/kg/dose every 2 hours as needed for pain score 4 or more. Midazolam will also be given as needed (0.05 mg/kg/dose every 1 hour)
Arm Title
As needed dosing
Arm Type
Active Comparator
Arm Description
Patients in this arm will be given doses of morphine 0.05 mg/kg/dose every 2 hours as needed for pain score 4 or more. Midazolam will also be given as needed (0.05 mg/kg/dose every 1 hour)
Intervention Type
Drug
Intervention Name(s)
continuous infusion
Other Intervention Name(s)
acetaminophen and ketorolac are scheduled for this arm of the study
Intervention Description
Continuous morphine/midazolam and 'as needed' doses. Will receive scheduled acetaminophen and ketorolac.
Intervention Type
Drug
Intervention Name(s)
as needed dosing
Other Intervention Name(s)
acetaminophen and ketorolac are both scheduled for this arm as well
Intervention Description
morphine and midazolam as needed. Will receive scheduled acetaminophen and ketorolac..
Intervention Type
Drug
Intervention Name(s)
Acetaminophen
Intervention Description
Acetaminophen will be given every 4 hours for a total of 24 hours.
Intervention Type
Drug
Intervention Name(s)
ketorolac
Intervention Description
Ketorolac 0.5 mg/kg will be given every six hours to all subjects in the study.
Primary Outcome Measure Information:
Title
Total Morphine Dosage
Description
Total dose of morphine used will be recorded for each patient.
Time Frame
24 hours
Secondary Outcome Measure Information:
Title
Length of Stay
Description
Length of stay will be recorded for each subject.
Time Frame
From date of randomization until the date of first documented progression or date of death from any cause or discharge, whichever came first, assessed up to 100 months
10. Eligibility
Sex
All
Minimum Age & Unit of Time
3 Months
Maximum Age & Unit of Time
4 Months
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Age 3 months - 4 years (48 months)
Anticipated cardiothoracic surgery with midline sternotomy incision
Planned early extubation (e.g. within 3 hours post surgery)
Exclusion Criteria:
Presence of renal insufficiency defined as a creatinine greater than 0.8mg/dL on the standard basic metabolic profile sent after surgery or history of chronic renal failure.
Significant development delay that the bedside nurse or treating physician judges would make pain scoring difficult (Down syndrome is not excluded)
History of bleeding disorder or gastrointestinal bleed within the past 2 months.
Presence of chronic hepatic disease or elevation of AST or ALT greater than 250 U/L before or after surgery.
More than 3 previous surgeries with a sternotomy incision (this may alter pain perception).
Children on immunosuppressants
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Jamie S Penk
Organizational Affiliation
Advocate Children's Hospital
Official's Role
Principal Investigator
Facility Information:
Facility Name
Advocate Children's Hospital
City
Oak Lawn
State/Province
Illinois
ZIP/Postal Code
60453
Country
United States
12. IPD Sharing Statement
Plan to Share IPD
No
Learn more about this trial
Continuous Infusion Versus Bolus Dosing for Pain Control After Pediatric Cardiothoracic Surgery
We'll reach out to this number within 24 hrs